Search results
Stock Market Hits A Wall Despite Booming Nvidia: Weekly Review
Investor's Business Daily· 5 hours agoBut the chipmaker's sales and earnings have fallen for four straight quarters. However, CEO Vincent ...
Intel Stock Spotlight: What's Happening With Semiconductor Play INTC Right Now?
InvestorPlace· 9 hours agoDon’t sleep on Intel (NASDAQ:INTC) even though Intel stock is clearly overshadowed by rivals Nvidia...
The Zacks Analyst Blog Highlights Stocks recently featured in the blog include: Novo Nordisk, Eli...
Zacks via Yahoo Finance· 4 days agoYou can see the complete list of today’s Zacks #1 ... Haven’t You Looked at Zacks' Top Stocks? Since...
Roche (RHHBY) Cancer Drug Gets Breakthrough Therapy Designation
Zacks via Yahoo Finance· 3 days agoRoche's (RHHBY) inavolisib gets Breakthrough Therapy Designation in the United States for advanced...
Pharma Stock Roundup: AZN's 2030 Sales Target, PFE's New Cost Cut Plan & More
Zacks via Yahoo Finance· 5 hours agoAstraZeneca (AZN) announces an ambitious target of achieving $80 billion in revenues by 2030. Pfizer...
Ginkgo Bioworks Stock Has 37.5% Downside, According to 1 Wall Street Analyst
Motley Fool via Yahoo Finance· 4 days agoStock Advisor returns as of May 13, 2024 Rich Smith has no position in any of the stocks mentioned....
Why Is Biogen (BIIB) Up 7.7% Since Last Earnings Report?
Zacks via Yahoo Finance· 3 hours agoVGM Scores At this time, Biogen has a nice Growth Score of B, however its Momentum Score is doing a...
Puma Biotechnology (PBYI) Falls 38% in 3 Months: Here's Why
Zacks via Yahoo Finance· 3 hours agoSales of Puma Biotechnology's (PBYI) sole marketed drug, Nerlynx, have been declining in recent...
Director At Exelixis Sells $576K Of Stock - Exelixis (NASDAQ:EXEL)
Benzinga· 4 hours agoA substantial insider sell was reported on May 23, by Julie Smith, Director at Exelixis EXEL, based on the recent SEC filing. What Happened: Smith's recent Form 4 filing with the U.S. Securities ...
This Biotech Stock Is Poised For 80% Upside With Breakthrough In Obesity Drug Market, Says JPMorgan...
Benzinga· 3 days agoThe Structure Therapeutics GPCR stock has been identified as a potential winner in the obesity drug...